NACL Industries Ltd
NACL is an established player and they deal in both technicals and formulations and they cater to the Indian market and to the international market as well. They have over 50 products covering all major crops. They have a strong logistic presence and the products are sold in more than 55,000 counters. NACL has become one of the reliable contract manufacturers for major MNCs. NACL exports products to over 30 countries and has forayed into International Brand business by registering brands in South-East Asia and Africa and are in the process of expanding reach in these regions. [1] [2]
- Market Cap ₹ 1,352 Cr.
- Current Price ₹ 67.8
- High / Low ₹ 105 / 55.4
- Stock P/E
- Book Value ₹ 26.9
- Dividend Yield 1.03 %
- ROCE 15.2 %
- ROE 18.0 %
- Face Value ₹ 1.00
Pros
Cons
- Company has low interest coverage ratio.
- Company might be capitalizing the interest cost
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Agro Chemicals Industry: Pesticides / Agrochemicals - Indian
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
643 | 601 | 636 | 746 | 692 | 735 | 847 | 865 | 1,015 | 1,191 | 1,633 | 2,116 | 1,920 | |
572 | 583 | 625 | 701 | 636 | 679 | 798 | 852 | 946 | 1,078 | 1,495 | 1,922 | 1,847 | |
Operating Profit | 71 | 18 | 11 | 44 | 56 | 56 | 49 | 14 | 69 | 113 | 138 | 193 | 73 |
OPM % | 11% | 3% | 2% | 6% | 8% | 8% | 6% | 2% | 7% | 10% | 8% | 9% | 4% |
4 | 18 | 16 | 26 | 18 | 41 | 20 | 27 | 8 | 15 | 13 | 10 | 10 | |
Interest | 33 | 31 | 28 | 35 | 37 | 38 | 33 | 34 | 29 | 28 | 27 | 47 | 74 |
Depreciation | 27 | 25 | 22 | 25 | 27 | 28 | 20 | 20 | 24 | 25 | 25 | 28 | 29 |
Profit before tax | 14 | -20 | -23 | 10 | 11 | 31 | 15 | -13 | 24 | 75 | 100 | 128 | -19 |
Tax % | 49% | 36% | 9% | 27% | 18% | -4% | 25% | 48% | 30% | 32% | 26% | 26% | |
7 | -13 | -21 | 8 | 10 | 33 | 12 | -7 | 17 | 51 | 73 | 95 | -16 | |
EPS in Rs | 0.40 | -0.70 | -1.32 | 0.54 | 0.62 | 2.09 | 0.74 | -0.42 | 0.87 | 2.60 | 3.70 | 4.77 | -0.81 |
Dividend Payout % | 31% | 0% | 0% | 19% | 16% | 6% | 17% | 0% | 12% | 15% | 15% | 15% |
Compounded Sales Growth | |
---|---|
10 Years: | 13% |
5 Years: | 20% |
3 Years: | 28% |
TTM: | -4% |
Compounded Profit Growth | |
---|---|
10 Years: | 25% |
5 Years: | 51% |
3 Years: | 78% |
TTM: | -120% |
Stock Price CAGR | |
---|---|
10 Years: | 25% |
5 Years: | 18% |
3 Years: | 5% |
1 Year: | -31% |
Return on Equity | |
---|---|
10 Years: | 9% |
5 Years: | 12% |
3 Years: | 16% |
Last Year: | 18% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 15 | 15 | 16 | 16 | 16 | 16 | 16 | 17 | 19 | 20 | 20 | 20 | 20 |
Reserves | 192 | 180 | 159 | 162 | 170 | 213 | 223 | 247 | 338 | 397 | 469 | 554 | 516 |
220 | 177 | 219 | 228 | 232 | 213 | 237 | 210 | 268 | 202 | 531 | 724 | 775 | |
204 | 228 | 227 | 260 | 193 | 209 | 237 | 268 | 330 | 357 | 496 | 616 | 637 | |
Total Liabilities | 631 | 600 | 621 | 665 | 611 | 651 | 713 | 742 | 955 | 976 | 1,516 | 1,914 | 1,948 |
192 | 172 | 182 | 176 | 167 | 163 | 158 | 141 | 191 | 220 | 238 | 402 | 447 | |
CWIP | 16 | 11 | 18 | 12 | 6 | 7 | 5 | 21 | 42 | 36 | 116 | 71 | 32 |
Investments | 4 | 4 | 9 | 12 | 13 | 9 | 9 | 14 | 15 | 16 | 13 | 14 | 15 |
419 | 413 | 411 | 466 | 426 | 473 | 541 | 566 | 707 | 704 | 1,148 | 1,427 | 1,454 | |
Total Assets | 631 | 600 | 621 | 665 | 611 | 651 | 713 | 742 | 955 | 976 | 1,516 | 1,914 | 1,948 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
36 | 76 | 31 | 40 | 46 | 58 | 24 | 36 | 103 | 83 | -124 | -20 | |
-24 | -5 | -47 | -18 | -12 | -6 | -14 | -27 | -97 | 14 | -163 | -143 | |
-10 | -74 | 11 | -27 | -33 | -58 | -11 | -9 | 70 | -113 | 290 | 134 | |
Net Cash Flow | 2 | -3 | -5 | -4 | 1 | -5 | -1 | 0 | 77 | -16 | 2 | -28 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 111 | 100 | 92 | 108 | 99 | 110 | 124 | 113 | 129 | 103 | 118 | 133 |
Inventory Days | 148 | 154 | 140 | 138 | 153 | 189 | 141 | 134 | 84 | 100 | 124 | 112 |
Days Payable | 123 | 113 | 97 | 121 | 89 | 127 | 127 | 125 | 137 | 120 | 112 | 110 |
Cash Conversion Cycle | 135 | 141 | 135 | 125 | 163 | 172 | 137 | 122 | 76 | 83 | 129 | 135 |
Working Capital Days | 108 | 97 | 93 | 90 | 119 | 126 | 124 | 125 | 90 | 89 | 123 | 128 |
ROCE % | 3% | 2% | 11% | 12% | 10% | 11% | 4% | 10% | 17% | 15% | 15% |
Documents
Announcements
-
Announcement Under Regulation 30 (LODR)-Newspaper Publication
1d - NACL Industries Limited has informed the Exchange about copy of Newspaper Publication.
- Announcement Under Regulation 30 LODR 1d
- NACL Industries Limited Has Informed The Exchange Regarding Notice Of Postal Ballot 2d
- Board Meeting Intimation for Reconvening The Board Meeting Scheduled To Be Held On Thursday, May 30, 2024 Mainly To Consider And Approve The Audited Financial Results For Financial Year Ended March 31, 2024 2d
- Board Meeting Outcome for NACL Industries Limited Has Informed The Exchange Regarding Reconvening The Board Meeting Scheduled To Be Held On Thursday, May 30, 2024 Mainly To Consider And Approve The Audited Financial Results For Financial Year Ended March 31, 2024 2d
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
-
Financial Year 2009
from bse
Concalls
-
Feb 2024TranscriptNotesPPT
-
Jan 2024TranscriptNotesPPT
-
Sep 2023TranscriptNotesPPT
-
Jun 2023TranscriptNotesPPT
-
Feb 2023TranscriptNotesPPT
-
Nov 2022TranscriptNotesPPT
-
Aug 2022TranscriptNotesPPT
-
May 2022TranscriptNotesPPT
-
Jan 2022TranscriptNotesPPT
-
Jan 2022TranscriptNotesPPT
-
Nov 2021TranscriptNotesPPT
-
Aug 2021TranscriptNotesPPT
-
Jun 2021TranscriptNotesPPT
-
Mar 2021TranscriptNotesPPT
-
Dec 2020TranscriptNotesPPT
Products[1]
Key technicals:
Insecticides: Cairo, Fenny, Nagarjuna 4G, PestLock, etc.
Herbicides: Font, Slogan, Nagarjuna Combi plus, etc.
Fungicides: Combi plus, Kazan, Result, Subtle Plant Growth Regulators :Atonik, Gallant EG, Gallant Gold
Company has 63 branded products.[2]